background: Grafting of frozen-thawed testicular tissue has been suggested as a novel fertility preservation method for patients undergoing gonadotoxic treatments. However, this technique still needs further optimization before any clinical application. So far, grafting of human testicular tissue has only been performed to the back skin of nude mice and has shown spermatogonial stem-cell survival and occasionally differentiation up to primary spermatocytes. In this study, orthotopic grafting to mouse testes was evaluated as an alternative, and the effect of freezing and the donor's age was studied.
Introduction
Gonadotoxic treatments during childhood are a common cause of male infertility because of germ cell loss (Howell and Shalet, 2001 ). In 1994, it was reported that spermatogenesis can be restored after injecting spermatogonial stem cells in an otherwise sterile mouse testis (Brinster and Zimmermann, 1994) . This technique, called spermatogonial stem-cell transplantation (SSCT), may thus offer the possibility to restore fertility in oncological patients by preserving their spermatogonial stem cells before therapy, followed by transplantation after being cured (Brinster and Zimmermann, 1994; Schlatt and Nieschlag, 2001 ). Ever since the first report, efforts have been made to further develop this fertility preservation strategy for clinical application. Also, testicular tissue grafting has been suggested as an alternative to SSCT. Mature spermatozoa were obtained from ectopic testicular grafts from newborn mice (Honaramooz et al., 2002) , and the fertilization capacity of spermatozoa produced in ectopic grafts was confirmed by the birth of progeny using intracytoplasmic injection (Schlatt et al., 2003) . Full spermatogenesis was obtained in grafts using immature testis tissue from different species: mice, pigs, goats, hamsters, bulls and rhesus monkey's (Honaramooz et al., 2002 (Honaramooz et al., , 2004 Schlatt et al., 2002; Oatley et al., 2004) . Although ectopic grafting of immature rhesus monkey testicular tissue resulted in full spermatogenesis, limited success was achieved when tissue from marmoset monkeys was used. Four and a half months after grafting, spermatocytes were the most advanced germ cells present Honaramooz et al., 2004; Rathi et al., 2008) . Ectopic grafting was also performed using human testicular tissue. The first reports using adult testicular tissue showed only limited spermatogonial survival (SS), whereas most of the tubules showed complete regression of spermatogenesis (Geens et al., 2006; Schlatt et al., 2006) . When fetal tissue was grafted to the back skin of nude mice, further development into a prepubertal pattern was described. An increase in graft weight, Sertoli cell differentiation and formation of a niche-like structure was observed, and gonocytes had migrated to the basal lamina (Yu et al., 2006) . SS (Goossens et al., 2008) and recently differentiation up to primary spermatocytes (Sato et al., 2010) were reported in ectopic grafts using prepubertal and neonatal tissue, respectively. In an attempt to improve the results after grafting, long-term survival of spermatogonia and differentiation up to pachytene spermatocytes was observed when immature testicular tissue was placed in the peritoneal bursa inside the scrotum, after castration of the acceptor mouse. Spermatid-like structures could be observed but their presence could not be confirmed by immunohistochemistry using meiotic and post-meiotic markers (Wyns et al., 2008) .
A few years ago, Shinohara et al. (2002) introduced intratesticular tissue transplantation. Such orthotopic grafting may have the advantage that spermatogonial stem cells remain in their natural environment. Production of mature sperm was reported after grafting cryopreserved immature testicular tissue from mice and rabbits into the testicular parenchyma. Progeny were born when rabbit sperm from the xenograft was used for microinsemination. In a recent publication, we compared the two available techniques for fertility restoration, i.e. intratesticular grafting and SSCT. We observed more donor-derived spermatogenesis after intratesticular grafting compared with SSCT (Van Saen et al., 2009) and concluded that orthotopic grafting may produce optimal results in fertility-preservation strategies. In a clinical setting, testicular tissue from boys with different ages will be obtained and these samples will have to be cryopreserved before any grafting can be performed.
In this study, we therefore aimed at evaluating the effects of cryopreservation and donor age on SS and differentiation capacity after intratesticular prepubertal grafting.
Materials and Methods

Human tissue donors
Human testicular tissue was obtained from four patients, aged 3, 5, 12 and 13 years. All patients were undergoing testicular biopsy before receiving a conditioning chemotherapy for bone marrow transplantation. The 3-and 5-year-old patients were treated for malignant diseases, i.e. neuroblastoma and leukemia, respectively. The 12-and 13-year-old boys suffered, respectively, from a chronic granulomatous disease and a therapy-resistant beta thalassemia major, which both require bone marrow transplantation. The two younger boys already received chemotherapy before biopsy. The two older boys did not receive any chemotherapy, but did receive other drugs for their disease. Information about the received treatment is shown in Table I . One-half of a testis was removed from the patient, and 90% of this testicular biopsy was cryopreserved for later use. One fragment was stored in hydrosafe fixative (R10 S7-16-60, Labonord, Rekkem, Belgium) for reference histology and immunohistochemistry. A small part of the tissue was used for the transplantation experiments after obtaining written informed consent from the boy's parents. The experiments were approved by the internal review board of the UZ Brussel (FWO 2004 /17D, 29 April 2004 .
Freezing
Testicular tissue was first immersed in sterile physiological solution and transported on ice water to the laboratory within 30 min. The tissue was cut into fragments of 6 mm 3 and washed twice in Dulbecco's modified Eagle's medium (DMEM; 31330-038, Invitrogen, Merelbeke, Belgium). Two testicular pieces were stored in each vial, containing 1.0 ml of cryopreservation medium and were put into ice water for 15 min. Cryopreservation medium was the same as for long-term storage and consisted of DMEM supplemented with 10% human serum albumin (HSA; 10064, Vitrolife, Gothenburg, Sweden), 1.4 M dimethylsulfoxide (DMSO; D2650, Sigma, Bornem, Belgium) and 150 mM sucrose (10274, BDH Laboratory Supplies, Poole, UK). The vials were put in a freezing container Mr Frosty Freezing Container, Mr Frosty, VWR, Leuven, Belgium) and stored overnight in a freezer at 2808C. The next day, the vials were transferred to liquid nitrogen. Just before transplantation, the pieces were thawed in a water bath at 378C and washed twice in DMEM supplemented with 10% HSA, to remove the remaining cryoprotectant, and were kept on ice until transplantation (Izadyar et al., 2002) .
Surgical procedure
Testicular tissue pieces (fresh and/or frozen-thawed) were transplanted to the testis of 4 -6-week-old Swiss Nu/Nu mice (n ¼ 13) (Charles River Laboratories, Brussels, Belgium). Mice were anesthetized using a mixture of medetor (0.1 mg/ml; Virbac Animal Health, Waver, Belgium) and ketamine (0.75 mg/ml; CeVA Santé Animale, Brussels, Belgium). Per 10 g body weight, 75 ml of this mixture was injected intraperitoneally. During the surgery, the mice were placed on a heating plate at 378C to avoid cooling. The testes were exteriorized through a mid-abdominal incision. A small incision was made in the tunica albuginea, and some tubules were removed from the testis until the testicular graft (1.5 mm 3 ) could be inserted. After insertion, the tunica was closed using a non-absorbable suture (U7003, 10-0; Eticon, Instruvet, Beringen-Paal, Belgium). After surgery, mice were given a subcutaneous injection with antibiotics (Baytril 2.5%, diluted 1/10; Bayer, Brussels, Belgium) and placed on a heating plate at 378C until waking up. The mice were housed individually in filter-cover cages and maintained in a 14-h/10-h light/dark cycles and with free access to sterilized pelleted diet and water. In all mice, a murine testicular piece was grafted to serve as a control for the grafting technique. Murine donors (n ¼ 6) were male GFP + F 1 hybrids from 5 to 7 days old, which were bred in the animal centre of the Vrije Universiteit Brussel according to the following breeding model: male C57BL inbred (Iffa Credo, Brussels, Belgium) × female SV129 inbred GFP + (gift from the Whitehead Institute for Biomedical Research, Cambridge, MA, USA). In the latter strain, green fluorescent protein (GFP) is under the control of the b-actin promotor and is expressed in all cell types. Murine donors were killed by decapitation, the testes were isolated and the tunica was removed. Testes were cut in half and stored in DMEM supplemented with 10% fetal bovine serum (FBS; 10500-056, Invitrogen) on ice until transplantation. The experiments were approved by the Animal Care and Use Committee of the Vrije Universiteit Brussel (08-395-1, 29 September 2008).
Histology
Mice were killed either 4 or 9 months after transplantation by cervical dislocation. The testes were collected, the tunica was removed and testes were fixed in hydrosafe fixative for at least 1 h. After embedding in paraffin, the whole testis was cut into consecutive 5 mm serial sections. For every nine slides, a hematoxylin -eosin staining was performed to localize Orthotopic xenografting of human testicular tissue the human testicular graft in the murine testis and to evaluate tubule integrity. The presence of well-preserved cell adhesion, the attachment of cells to the basal lamina and the presence of fibrosis were evaluated. Intact tubules were scored for the presence of the most advanced cell type.
Immunohistochemistry
Consecutive slides were used for immunohistochemistry for Melanomaassociated antigen 4 (MAGE-A4) (mouse monoclonal antibody, provided by Giulio Spagnoli, University of Basel, Switzerland) as a human-specific spermatogonial marker, Vimentin (mouse monoclonal antibody clone V9, M0725, Dako, Heverlee, Belgium) as a human-specific Sertoli cell marker, anti-mullerian hormone (AMH) (mouse monoclonal antibody, MCA2246, AbD Serotec, Düsseldorf, Germany) as a marker for immature Sertoli cells, inhibin a (mouse monoclonal antibody clone R1, M3609, Dako) and stem-cell factor (SCF; rabbit monoclonal antibody, ab52603, Abcam, Cambridge, UK) as markers for the functionality of Sertoli cells and Boll (H00066037-M03Novus Biologicals, Cambridge, UK) as a meiotic marker. Green fluorescent antibody (mouse monoclonal antibody, sc-9996, Tebu-bio, Boechout, Belgium) was used to detect and evaluate the presence of full spermatogenesis in the GFP + murine control tissue.
After deparaffinization and rehydration, slides were washed in phosphate-buffered saline. Endogeneous peroxidases were blocked by incubation in 0.3% H 2 O 2. Antigen retrieval was performed in citrate buffer, using a water bath at 958C for 75 min (for MAGE-A4, Vimentin, Boll, AMH and SCF) or at 988C for 75 min (for inhibin). The slides were cooled at room temperature for 30 min. Non-specific binding was blocked by incubating slides with 10% normal goat serum (NGS) and 1% bovine serum albumin (for inhibin), 4% NGS (for MAGE-A4, Vimentin, Boll, SCF and AMH) or 3% NGS (for GFP). Slides were subsequently incubated overnight at 48C with the primary antibody (1/200 for MAGE-A4, Vimentin, AMH and SCF, 1/400 for Boll, 1/100 for GFP, 1/50 for inhibin). Color reaction was achieved by using a staining kit containing peroxidaseconjugated polymer which carries antibodies to rabbit and mouse immunoglobulines. Chromogene reaction was performed using diaminobenzidine supplied with the kit (Dako Real Envision Detection System, K5007). Nuclei were counterstained with hematoxylin, and slides were dehydrated and mounted.
Only intact tubules were evaluated for the presence of the different markers and included in the MAGE-A4 calculations. On slides stained for MAGE-A4, the positive and negative tubules were determined, as well as the number of cells. From these numbers, the percentage of HE-stained slides were evaluated at the pathology department of our hospital. The presence of the most advanced germ cell stage present in each individual tubule inside the graft was morphologically determined. The difference between primary and secondary spermatocytes was determined on the different layers present in the tubule.
Results
Assessment of germ cell numbers in donor tissue
Donor testicular tissue was characterized using MAGE-A4 + staining.
The number of seminiferous tubules containing germ cells was determined as well as the number of positive cells per tubule. In all grafts, MAGE-A4 + cells could be observed (Table II) . After freezing, the testicular tissue was re-evaluated to determine the survival rate of the germ cells. From the 5-year-old boy, only fresh donor tissue was used for transplantation, and hence no data for freezing are available. From the 3-, 12-and 13-year-old boys, 27.3, 64.4 and 48.6% of the germ cells survived the freezing procedure, respectively (Table II) .
Recovery and integrity of the transplanted tissue
Thirteen mice had been transplanted with human prepubertal and postpubertal tissue. Because of the scarcity of the tissue, from the 3-year-old boy, only frozen tissue was transplanted to two mice, whereas from the 5-year-old boy only fresh tissue was transplanted. For the two older patients, a total of four mice were transplanted, two mice in which fresh tissue was grafted and two mice receiving frozen-thawed tissue. In all mice, a fresh prepubertal murine testicular tissue piece (from mice at 5-7 days old) was transplanted in the contralateral testis as a control for the technique. Half of the mice were killed after 4 months, whereas the rest was killed 9 months after transplantation. For the 13-year-old boy, one additional mouse was transplanted because there was human testicular tissue left. In this mouse, both testes received a human graft, and evaluation was performed 9 months after transplantation. After 4 months, murine tissue could be recovered from all but one graft (5 of 6 or 83.3%). In the group which was evaluated 9 months after transplantation, one mouse died. All remaining grafts (n ¼ 5) could be recovered. The GFP + tissue was located using immunohistochemistry for GFP and the amount of GFP + tubules with full spermatogenesis was determined (Fig. 1A and B) . Full spermatogenesis could be observed in all murine grafts (n ¼ 10) (Table II) . After 4 months, all grafts (n=3) from the testes in which a fresh human piece was transplanted could be recovered. From the three testes in which a frozen-thawed piece was transplanted, two could be recovered. Nine months after transplantation, all grafts (n ¼ 4) could be recovered in the group receiving fresh tissue, as well as in the group receiving frozen-thawed tissue (n ¼ 3) (Table II) .
The human testicular tissue was located using vimentin staining ( Fig. 1C and D) and the integrity of the tissue was determined. Degenerative tubules, tubules with deficient cell adhesion or deficient adhesion to the basement membrane, were not considered as intact tubules. Tubule integrity is represented in Fig. 1E . In the fresh grafts from the 5-year-old donor, 76.6% of the tubules were intact after 4 months and 83.9% of the tubules were intact after 9 months. In the frozen-thawed graft from the 3-year-old donor, 87.8 and 72.4% of the tubules were intact after 4 and 9 months, respectively. In the fresh grafts from the 12-and 13-year-old boys, 55.2 and 89.1% were intact after 4 months, respectively. Nine months after transplantation, 35.0% of the tubules from graft 1, 15.2% of the tubules from graft 2 and 70.2% of the tubules from graft 3 showed good integrity. After freezing, tubule integrity for the older boys was reduced after 4 months to 40.1% and even more after 9 months (0.0 and 23.3%, respectively).
Assessment of germ cell survival
Four months after transplantation
From the fresh testicular tissue obtained from the 5-year-old boy, only 7.9% of the surviving tubules contained MAGE-A4
+ with an average of 0.2 positive cells per tubule ( Fig. 2A and B) . In the 12-and 13-year-old boys, more MAGE-A4 + tubules (82.6 and 82.1%, respectively) could be observed with 7.3 cells per tubule in the graft from the 12-year-old boy and 9.4 cells per tubule in the graft from the 13-year-old patient ( Fig. 2D and E) . The SS was 3.0, 70.2 and 84.7% in the grafts from the 5-, 12-and 13-year-old boys, respectively (Table II) .
In the frozen-thawed group, 4.8% of the surviving tubules contained MAGE-A4 + cells, with 0.2 cells per tubule in the graft from the 3-year-old boy ( Fig. 2G and H) , whereas 38.0% of the tubules from the 12-year-old boy were positive, containing 2.5 cells per tubule ( Fig. 2J and K) . The SS (number of cells per tubule after grafting/ number of cells per tubule before grafting) between fresh and transplanted tissue was calculated as well as the survival between frozen-thawed and transplanted tissue (number of cells per tubule after grafting/number of cells per tubule after freezing). The SS (transplantation/fresh) was 9.1% for the young boy and 24.0% for the older boy, whereas the SS (transplantation/frozen) was 33.3 and 37.3%, respectively (Table II) .
Nine months after transplantation
The fresh graft from the 12-year-old boy could not be recovered because the recipient mouse died before the end of the experiment. In the graft from the 5-year-old boy, 5.0% of the tubules contained MAGE-A4 + cells, containing 0.5 cells per tubule corresponding with an SS of 7.5%. From the 13-year-old boy, 61.3, 62.2 and 82.3% of the tubules contained MAGE-A4 + cells in grafts 1-3, respectively.
The number of MAGE-A4 + cells per tubule was 7.2, 10.0 and 9.4 with corresponding SS rates of 64.9, 92.8 and 84.7% (Table II , Fig. 2C and F) . All grafts could be recovered from the frozen-thawed tissue, but the graft from the 12-year-old boy contained only degenerative tubules. As the MAGE-A4 determination was only performed on intact tubules, no data are available for this graft. In the remaining two grafts, 9.0% (0.6 cells per tubule) and 43.9% (6.7 cells per tubule) of the tubules contained MAGE-A4 + cells in the grafts from the 3-year-old boy and 13-year-old boy, respectively. The SS (transplantation/fresh) was 27.3% for the 3-year-old boy and 60.4% for the 13-year-old boy, whereas the SS (transplantation/frozen) was 100.0 and 124.1%, respectively (Table II , Fig. 2I and L).
Assessment of differentiation in human xenografts
All grafts (HE-stained) were analyzed at the pathology department of UZ Brussel. The most advanced germ cell stage present was evaluated in the pre-grafting tissue and in the grafts 4 and 9 months after transplantation. Before grafting, in the 3-and 5-year-old boys, the most advanced germ cells present were spermatogonia ( Fig. 3A and G) . In the 12-and 13-year-old boys, spermatogenesis was already initiated and proceeded up to the level of secondary spermatocytes ( Fig. 3B and G). In the 12-year-old boy, 32.0% of the tubules contained primary and 24.7% of the tubules contained secondary spermatocytes. In the 13-year-old boy, 33.7% of the tubules contained primary spermatocytes as the most advanced germ cell stage and secondary spermatocytes were present in 35.0% of the tubules. No expression of the meiotic marker Boll was observed in the 3-and 5-year-old boys (Fig. 3D) , whereas expression was observed in the pre-grafting tissue from the 12-and 13-year-old boys (Fig. 3E) . After grafting, tubular sclerosis was rarely observed in the grafts from the young patients. Sertoli cells showed an immature phenotype, and the most advanced spermatogenetic stage observed was at the level of spermatogonia. No expression from Boll was observed in the young grafts. In the grafts from the older patients, more tubular sclerosis was observed especially in frozen-thawed grafts. In some sections, calcifications were observed. Calcifications often occur as a reaction to tissue damage. Four months after transplantation, primary spermatocytes could be observed in 2.9% of the tubules in the fresh graft from the 12-year-old boy and in 0.5% of the tubules in the fresh graft from the 13-year-old boy. After 9 months, the grafts from the 13-year-old boy only could be recovered and primary spermatocytes were observed in 2.9% of the tubules in graft 1 and in 1.0% of the tubules in graft 3. Secondary spermatocytes were present in 0.2% of the tubules in graft 1 and in 9.2% of the tubules in graft 3 (Fig. 3C and G) . No differentiation was observed in graft 2. The presence of meiotic activity was confirmed by Boll expression (Fig. 3F) . In the frozen-thawed grafts, no spermatocytes could be observed except in the graft from the 12-year-old boy (0.8%).
Sertoli cell maturation and function
AMH is secreted by immature Sertoli cells (Rajpert-De Meyts et al., 1999) . Therefore, loss of expression of this marker in a testicular tissue graft is an indication for Sertoli cell maturation (Rathi et al., 2008) . AMH expression was examined in our donor materials before and after grafting. Before grafting, AMH was expressed less intensely in the older donors compared with that in the young donors, indicating maturity of the Sertoli cells in the older donors ( Fig. 4A and D) . Four months after transplantation, AMH was expressed in all tubules ( Fig. 4B and E) , but it was observed that 4 months after transplantation of the older testicular tissue, the intensity of AMH expression in the tubules was higher compared with fresh tissue. Nine months after transplantation, AMH was still expressed in young as well as in old donor grafts ( Fig. 4C and F) . However, it was observed that in tubules with ongoing differentiation, AMH expression was very weak (Fig. 4G and H) .
We also investigated the expression of two Sertoli cell secretion products, inhibin a and SCF. All grafts examined were positive for these two markers, indicating that the Sertoli cells were functional (Fig. 4I ).
Discussion
In this study, we evaluated the effect of donor's age and cryopreservation on intratesticular grafting as an alternative grafting site for human prepubertal tissue. Our results showed that human testis tissue is able to survive when transplanted into the testis of immuno-deficient mice and that spermatogenesis up to the level of secondary spermatocytes can be observed after 9 months. In previous reports using human testicular tissue, grafting was either performed under the back skin of immuno-deficient mice (Geens et al., 2006; Schlatt et al., 2006; Yu et al., 2006; Goossens et al., 2008; Sato et al., 2010) or in the scrotal bursa (Wyns et al., 2008) . When prepubertal human tissue was grafted to the back skin, only limited long-term survival of spermatogonia was reported (Goossens et al., 2008) , but when frozen-thawed tissue was transplanted into the scrotum, an average spermatogonial recovery of 3.7% was reported. The highest spermatogonial recovery (13.8%) could be observed in a 7-year-old patient (Wyns et al., 2008) . In 
Transplantation of frozen-thawed testicular tissue (G-L). Testicular tissue from a young donor after freezing (G). Four months (H) and 9 months (I)
after transplantation with frozen-thawed young tissue: tubule integrity is well preserved and MAGE-A4 + cells are present. Testicular tissue from an older donor (J, 13 years) after freezing. Four months (K, 12 years) and 9 months (L, 13 years) after transplantation with frozen-thawed tissue from older donors. Lots of degenerated tubules are visible in the graft from the 12-year-old donor after 4 months. In the graft from the 13-year-old donor, most of the tubules are intact and contain many MAGE-A4 + cells. Magnified pictures: ×320; insert pictures in the right corner, marked with ′ are corresponding images at ×100 showing an overview of the graft. Figure 3 HE staining of pre-grafting tissue from a 3-year-old donor (A): tubules consisting of Sertoli cells and spermatogonia. HE staining of pre-grafting tissue from a 13-year-old patient (B): spermatogenesis has been initiated and proceeds up to the level of secondary spermatocytes. Tubules of graft from the 13-year-old boy showing spermatogenesis up to secondary spermatocytes 9 months after transplantation (C). Boll staining of pre-grafting tissue from a 3-year-old donor (D): no meiotic activity is present. Boll staining of pre-grafting tissue from a 13-year-old patient (E): expression of Boll is visible, indicating the presence of meiotic activity. Expression of Boll (arrows) in tubules containing differentiated germ cells 9 months after grafting tissue from an older donor (F). Distribution of most advanced germ cell stage in the grafts (G). Uppermost panel shows the situation in pre-grafting tissue. Left panels show the results from the fresh tissue grafts 4 (upper panel) and 9 months (lower panel) after transplantation. Right panels show the results from the frozen-thawed grafts after 4 (upper panel) and 9 months (lower panel). Black arrowhead represents spermatogonia (spgia); unfilled arrowhead represents primary spermatocytes (1st spc); arrow represents secondary spermatocytes (2nd spc). SCO, Sertoli-cell-only tubules.
Orthotopic xenografting of human testicular tissue our previous research, we assessed the feasibility of grafting murine prepubertal testicular tissue inside the testicular parenchyma compared with SSCT. Spermatogenesis was re-established with both transplantation methods, however, more donor-derived spermatogenesis was observed after intratesticular grafting (Van Saen et al., 2009) .
In the present study, again using intratesticular grafting, the spermatogonial recovery was much higher compared with spermatogonial recovery after ectopic grafting, i.e. ranging from 3.0 to 84.7% when fresh tissue was transplanted and ranging from 9.1 to 124.1% when frozen-thawed tissue was transplanted. This indicates that human spermatogonia survive better when transplanted inside the testicular parenchyma. The observation that .100% of the spermatogonia survived indicates that spermatogonia are proliferating during the grafting period. However, spermatogonial recovery needs to be interpreted with care. MAGE-A4 is often used as a marker for spermatogonia, but is also expressed in primary spermatocytes which are also situated adjacent to the basement membrane (Takahashi et al., 1995) .
The advantage of orthotopic grafting is that the tissue is transferred into its natural environment including the presence of high testosterone levels and not being exposed to hyperthermic conditions as may be the case with subcutaneous grafting. Meiotic arrest was reported in ectopic marmoset testicular grafts, whereas complete spermatogenesis was observed in scrotal transplants (Luetjens et al., 2008) . In women too, intra-ovarian transplantation has been performed after gonadotoxic treatments with follicular development and restoration of ovulatory cycles (Donnez et al., 2004) .
Our current findings show that an intratesticular grafting technique, as described here, provides optimal results in terms of graft survival and functionality.
However, in order to further develop any clinical application, the effect of donor's age and cryopreservation on survival and functionality must be investigated.
Recently, initiation of spermatogenesis up to the stage of primary spermatocytes was reported when testicular tissue from a 3-monthold boy was grafted subcutaneously (Sato et al., 2010) . In two 14-year-old boys, in which focal spermatogenesis was already present, very low recovery rates and a lot of sclerosis was observed (Wyns et al., 2008) .
In our study, in the older donors, spermatogenesis was also initiated at the time of transplantation, but with a high number of MAGE-A4 + cells in the fresh grafts. Nine months after transplantation, meiotic activity was still present in some tubules up to the level of secondary spermatocytes. However, differentiation was only seen in the fresh grafts from the two older donors. It was reported earlier that donor age has an effect on testicular graft outcome (Oatley et al., 2005; Schmidt et al., 2006a; Abrishami et al., 2010) . In bull studies, it has been hypothesized that spermatogenic progression in donor tissue, in which spermatocytes are already present at the time of grafting, may be more efficient, whereas the presence of advanced germ cells may be associated with poor graft development (Huang et al., 2008) . According to the hypothesis that spermatogenesis must be re-initiated after grafting from spermatogonial stem cells or early differentiating stem cells (Huang et al., 2008) , the meiotic germ cells observed in the grafts are not surviving germ cells but evidence of re-initiated spermatogenesis from surviving stem cells. This is also confirmed by the fact that more differentiation is present 9 months after grafting compared with 4 months post grafting. A possible explanation for the lack of differentiation in grafts from younger donors is that the stem cells in older donors are 'primed' to differentiate. Recently, it was reported in mice that A s stem cells undergo a shift in gene expression of growth-factor-receptor alpha (GFRa + ) to Neu- (Nakagawa et al., 2010) . The lower cell survival and lack of differentiation in the young patients could also be caused by the fact that these patients already received chemotherapy before the biopsy was taken. Although the percentages of tubules containing Mage-A4 + cells were in the same range in all the patients, less MAGE-A4 + cells per tubule were observed in the young patients. The SS was also much lower in the young patients compared with the older patients. This could mean that less spermatogonia survived the grafting period or that spermatogonia lost their proliferation and differentiation potentials due to the chemotherapy. A possible explanation could be that the spermatogonia lost their functionality due to the chemotherapy. The 12-year-old boy received treatment with interferon gamma. Interferon gamma can also affect fertility. Delayed sexual maturation, reduced epididymal and testical weights, and altered sperm parameters (reduced sperm count and motility) have been observed in mice (Bussiere et al., 1996) . This illustrates the importance of preserving the testicular tissue before receiving any therapy. The expression of AMH in the Sertoli cells indicates that full maturity was not reached in the xenografts. Accelerated maturation in neonatal humans and immature primate xenografts has been reported (Honaramooz et al., 2004; Sato et al., 2010) . This was not observed in our study although AMH expression was almost absent in tubules in which differentiation occurred. Differentiation was only seen in the grafts from the older boys which already showed focal spermatogenesis before grafting. No differentiation occurred in the young xenografts, indicating that Sertoli cells from young donors may not have reached maturity in the 9-month grafting period.
Owing to the scarcity of prepubertal human tissue available for research, our study was performed with a small sample size and thus more comparative research is definitely necessary to confirm the differences observed according to the donor's age.
To study the effect of freezing on the results of intratesticular transplantation, we used a non-controlled slow freezing protocol with DMSO and sucrose as cryoprotectants (Izadyar et al., 2002) . After freezing, less MAGE-A4
+ cells were present in the donor tissue (SS ranging from 27.3 to 64.4%), indicating that many spermatogonia do not survive the freeze-thawing procedure. No differentiation was observed in the frozen-thawed grafts, indicating that the freezing procedure still needs to be improved. In a study from Jahnukainen et al. (2007) , the effect of different cryoprotectants has been assessed in a non-human primate model. The effect of freezing was evaluated using subcutaneous monkey xenografts. Spermatogenesis was found up to the level of pachytene spermatocyes. DMSO was found to have a superior effect on both graft survival and spermatogonial stemcell survival compared with ethylene glycol. However, a decrease in the number of seminiferous tubules containing spermatogonia was
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found as well as a delay in the initiation of spermatogenesis in the grafted tissue (Jahnukainen et al., 2007) . A variation in tubular integrity was observed. Apart from the age of the donor tissue, surgical deficiencies, i.e. bleeding or inefficient closure of the incision, might explain this finding. Bleeding during surgery can result in non-optimal revascularization of the graft with hypoxia as a consequence. Graft survival is known to be dependent on establishing continuity with the recipient's vascular system for the supply of oxygen and hormones. The connection to the vascular system is believed to be established by outgrowing capillaries from the donor tissue and formation of larger vessels from the host (Schlatt et al., 2010a,b) . The variability in graft development and tubular integrity may thus be associated with the restoration of the blood supply from the host. It was reported in mice that treatment with vascular endothelial growth factor (VEGF) at the time of grafting bovine tissue results in larger graft sizes and an increase in the percentage of seminiferous tubules containing elongating spermatids compared with non-treated controls (Schmidt et al., 2006b) . In future research, it might be interesting to investigate the effect of VEGF on intratesticular graft outcomes. Testicular maturation is supported by gonadotrophins. Another explanation for deficient maturation in xenografts may be an inefficient interaction between murine gonadotrophins and the donor tissue. In equine and infant monkey xenografts, exogenous administration of gonadotrophins resulted in improved maturation and supported postmeiotic differentiation (Zeng et al., 2006; Rathi et al., 2008) . In our study, differentiation was seen in older xenografts up to the secondary spermatocyte stage without administration of gonadotrophins, but there was no post-meiotic differentiation. Exogenous administration of human recombinant follicle-stimulating hormone may stimulate maturation and differentiation in the human xenografts which needs investigation in the future.
In a recent study, the effect of the endocrine environment of the host on graft development was reported. It was observed that the growth, maturation and differentiation of hamster grafts were independent of the amount of testicular tissue in the host, indicating that the graft growth and differentiation are intrinsically regulated, whereas the recipient performs a tight control on steroidogenic activity by maintaining the androgen levels always within the physiologically normal range (Schlatt et al., 2010a,b) . Figure 4 Immunostaining for AMH in fresh donor tissue and grafts from young (A -C) and older donors (D -F). Before transplantation AMH was expressed in young donors (A) and less intensely in the older donors (D). Four (B and E) and nine months (C and F) after transplantation, AMH was still expressed in grafts from young donors (B and C) as well as in grafts from older donors (E and F). Nine months after transplantation, AMH was very weakly expressed in tubules where differentiation was going on (rectangle in G). Tubules with differentiation (rectangle) were proven to be of human origin by vimentin staining (H). Expression of inhibin in same tubule (I).
Orthotopic xenografting of human testicular tissue
In conclusion, the results from the present study show that the intratesticular grafting technique provides optimal results in terms of graft survival and functionality with meiotic differentiation in fresh 9-month-old xenografts from older prepubertal donors.
Although the testicular parenchyma seems a very efficient grafting site, further differentiation in the grafts may be dependent on the donor's age and cryosurvival. Unfortunately, the scarcity of prepubertal human tissue available for research hampers extensive research to further elucidate factors interfering with graft survival and functionality such as age of the graft donor, cryopreservation protocol, addition of hormonal support or factors stimulating revascularization.
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